Clinical Trial Update: Insulin Glargine During and After the Period of Fasting in Ramadan [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed insulin glargine use during and after Ramadan fasting in people with Type 2 diabetes, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED